Stocks
Crinetics Pharmaceuticals, Inc.CRNX
NASDAQHealthcareBiotechnology$37.49+2.68%
A clinical-stage biotechnology company focused on developing oral small‑molecule therapies for endocrine diseases and rare hormone‑related disorders. Its pipeline includes treatments targeting conditions such as acromegaly, congenital adrenal hyperplasia, and Cushing’s disease, with several candidat...
Market Cap: $3.9B52W Range: $24.10 – $57.99
Congressional Interest in Crinetics Pharmaceuticals, Inc. (CRNX)
2 members of Congress have disclosed 4 trades in Crinetics Pharmaceuticals, Inc. (CRNX), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
2
Buys
3
Sells
1
Who in Congress Is Trading CRNX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-17 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-03-19 | Josh Gottheimer | sell | $1K – $15K |